No Data
No Data
Blueprint Medicines (NASDAQ:BPMC) Is Carrying A Fair Bit Of Debt
Blueprint Medicines Corporation (BPMC): Among the Oversold Biotech Stocks to Buy Now
Stifel Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $155
Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Blueprint Medicines (BPMC)
JMP Securities Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Raises Target Price to $126
Barclays Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $105